These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15868988)

  • 1. [Metabolic syndrome: limited significance for clinical practice].
    Dekker JM; Diamant M; Nijpels G; Heine RJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):855-8. PubMed ID: 15868988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The metabolic syndrome: a cluster of vascular risk factors].
    Olijhoek JK; Martens FM; Banga JD; Visseren FL
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):859-65. PubMed ID: 15868989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to best define the metabolic syndrome.
    Magliano DJ; Shaw JE; Zimmet PZ
    Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60].
    Bos MB; de Vries JH; Wolffenbuttel BH; Verhagen H; Hillege JL; Feskens EJ
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2382-8. PubMed ID: 18019216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk].
    Pacholczyk M; Ferenc T; Kowalski J
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():530-42. PubMed ID: 18936729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
    O'Neill S; O'Driscoll L
    Obes Rev; 2015 Jan; 16(1):1-12. PubMed ID: 25407540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of the metabolic syndrome.
    Daskalopoulou SS; Mikhailidis DP; Elisaf M
    Angiology; 2004; 55(6):589-612. PubMed ID: 15547646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of the metabolic syndrome, 2002.
    Meigs JB
    Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microvascular dysfunction as an explanation for the metabolic syndrome].
    Serné EH; de Jongh RT; Ijzerman RG; Stehouwer CD
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):866-70. PubMed ID: 15868990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations of Croatian societies on treatment of macrovascular and microvascular complications in patients with metabolic syndrome and diabetes type 2--treatment of residual risk].
    Reiner Z; Bozikov V; Car N; Knezević A; Kokić S; Metelko Z; Milicić D; Polić S; Zaputović L; Zjacić-Rotkvić V
    Lijec Vjesn; 2009; 131(1-2):1-3. PubMed ID: 19348347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and the metabolic syndrome].
    Olsen MH; Jeppesen J; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(25):2107-9. PubMed ID: 19671392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.